SEC Filings

Filing date	Form	Description	View
08/25/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-094421.pdf 0001104659-22-094421.rtf 0001104659-22-094421.xls
08/25/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-094423.pdf 0001104659-22-094423.rtf 0001104659-22-094423.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008979.pdf 0001415889-22-008979.rtf 0001415889-22-008979.xls
08/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008981.pdf 0001415889-22-008981.rtf 0001415889-22-008981.xls
08/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008983.pdf 0001415889-22-008983.rtf 0001415889-22-008983.xls
08/23/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008985.pdf 0001415889-22-008985.rtf 0001415889-22-008985.xls
08/18/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008835.pdf 0001415889-22-008835.rtf 0001415889-22-008835.xls
08/11/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008512.pdf 0001415889-22-008512.rtf 0001415889-22-008512.xls
08/08/22	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-22-012666.pdf 0001558370-22-012666.rtf 0001558370-22-012666.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/08/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-087373.pdf 0001104659-22-087373.rtf

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.